Zhejiang Jiangbei Pharmaceutical

Zhejiang Jiangbei Pharmaceutical is a specialized Chinese pharmaceutical company focused on the development and large-scale production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. As a key subsidiary of Zhejiang Xianju Pharmaceutical, the company maintains a strong market presence in therapeutic areas such as antivirals, cardiovascular health, and immunosuppressants. Their extensive product portfolio includes high-volume molecules like acyclovir, atorvastatin, and mycophenolate mofetil, produced under strict GMP compliance. The company operates advanced manufacturing facilities in Zhejiang province and serves a global customer base across Asia, Europe, and the Americas. In addition to its own product line, Zhejiang Jiangbei Pharmaceutical provides contract manufacturing and development services to international partners.